1995-06-08
Autologous and allogeneic blood transfusions in colorectal cancer
Publication
Publication
Autologe en allogene bloedtransfusies bij het colorectaal carcinoom
Since blood transfusion became a therapeutical option in patient care, the surgical possibilities have increased tremendously. Since the problems of anticoagulation and blood group typing were largely resolved, blood transfusions were in only a minority of cases directly lethal. However, it was estimated that still up to 20% of the blood transfusions induces a sort of adverse side-effect. Because the most important side-effects are a result of the transmission of infections and the induction of immunological reactions, these are further discussed.
| Additional Metadata | |
|---|---|
| , , , | |
| Dutch Cancer Society (KWF), Dutch Foundation for Preventive Medicine | |
| J. Jeekel (Hans) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/21761 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Busch, O. (1995, June 8). Autologous and allogeneic blood transfusions in colorectal cancer. Retrieved from http://hdl.handle.net/1765/21761 |
|
| Additional Files | |
|---|---|
| stellingen busch.pdf , 53kb | |
| 1118_BUSCH, Olivier Robert Christoffel.jpg Cover Image , 14kb | |
